These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 16697876

  • 1. Re: treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Olapade-Olaopa EO, Adebayo SA.
    J Urol; 2006 Jun; 175(6):2365-6; author reply 2366. PubMed ID: 16697876
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
    Schaeffer AJ, Wu SC, Tennenberg AM, Kahn JB.
    J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
    [Abstract] [Full Text] [Related]

  • 3. National guideline for the management of prostatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
    Sex Transm Infect; 1999 Aug; 75 Suppl 1():S46-50. PubMed ID: 10616384
    [No Abstract] [Full Text] [Related]

  • 4. Levofloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis: a randomized double-blind multicenter study.
    Bundrick W, Heron SP, Ray P, Schiff WM, Tennenberg AM, Wiesinger BA, Wright PA, Wu SC, Zadeikis N, Kahn JB.
    Urology; 2003 Sep; 62(3):537-41. PubMed ID: 12946763
    [Abstract] [Full Text] [Related]

  • 5. [Etiotropic therapy of chronic bacterial prostatitis].
    Popov SV, Mazo EB.
    Urologiia; 2008 Sep; (3):36, 38-41. PubMed ID: 18669346
    [Abstract] [Full Text] [Related]

  • 6. Value of antibiotic therapy for bioptically proved chronic prostatitis.
    Kertes P, Goncalves F, Stefancik J, Dubravicky J, Hladik M, Breza J.
    Bratisl Lek Listy; 2008 Sep; 109(1):42. PubMed ID: 18447263
    [No Abstract] [Full Text] [Related]

  • 7. Clinical significance of nontraditional bacterial uropathogens in the management of chronic prostatitis.
    Nickel JC, Xiang J.
    J Urol; 2008 Apr; 179(4):1391-5. PubMed ID: 18289570
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of ofloxacin (tarivid) in patients with chronic bacterial prostatitis: preliminary results.
    Pust RA, Ackenheil-Koppe HR, Gilbert P, Weidner W.
    J Chemother; 1989 Jul; 1(4 Suppl):869-71. PubMed ID: 16312678
    [No Abstract] [Full Text] [Related]

  • 9. Management of bacterial prostatitis: what's new?
    Naber KG.
    BJU Int; 2008 Mar; 101 Suppl 3():7-10. PubMed ID: 18307679
    [Abstract] [Full Text] [Related]

  • 10. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model.
    Lee YS, Han CH, Kang SH, Lee SJ, Kim SW, Shin OR, Sim YC, Lee SJ, Cho YH.
    Int J Urol; 2005 Apr; 12(4):383-9. PubMed ID: 15948727
    [Abstract] [Full Text] [Related]

  • 11. [Diagnosis and treatment of prostatitis: a case report].
    Braham I, Charefeddine B, Neffatti S, Othmane LB, Smach M, Letaief A, Dridi H, Limem K.
    Ann Biol Clin (Paris); 2009 Apr; 67(5):577-80. PubMed ID: 19789132
    [Abstract] [Full Text] [Related]

  • 12. [Local antibiotic therapy in the treatment of chronic bacterial prostatitis].
    Muntañola P, Pertusa C, Martínez-Piñeiro JA.
    Arch Esp Urol; 1980 Apr; 33(3):261-6. PubMed ID: 6994663
    [Abstract] [Full Text] [Related]

  • 13. [Infectious pathologies of the prostate].
    Vanden Bossche M.
    Rev Med Brux; 1999 Sep; 20(4):A219-21. PubMed ID: 10523896
    [Abstract] [Full Text] [Related]

  • 14. Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.
    Magri V, Marras E, Skerk V, Markotić A, Restelli A, Garlaschi MC, Perletti G.
    Andrologia; 2010 Dec; 42(6):366-75. PubMed ID: 21105887
    [Abstract] [Full Text] [Related]

  • 15. [Comprehensive therapy for chronic bacterial prostatitis: report of 52 cases].
    Zhou DQ, Wen HT, Tan WL.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):368-9. PubMed ID: 12390750
    [Abstract] [Full Text] [Related]

  • 16. The rapid development of fluoroquinolone resistance in M. tuberculosis.
    Ginsburg AS, Woolwine SC, Hooper N, Benjamin WH, Bishai WR, Dorman SE, Sterling TR.
    N Engl J Med; 2003 Nov 13; 349(20):1977-8. PubMed ID: 14614180
    [No Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory and antimicrobial effects of garlic and synergistic effect between garlic and ciprofloxacin in a chronic bacterial prostatitis rat model.
    Sohn DW, Han CH, Jung YS, Kim SI, Kim SW, Cho YH.
    Int J Antimicrob Agents; 2009 Sep 13; 34(3):215-9. PubMed ID: 19375896
    [Abstract] [Full Text] [Related]

  • 18. Oral levofloxacin 500 mg once daily in the treatment of chronic bacterial prostatitis.
    Naber KG, Roscher K, Botto H, Schaefer V.
    Int J Antimicrob Agents; 2008 Aug 13; 32(2):145-53. PubMed ID: 18571904
    [Abstract] [Full Text] [Related]

  • 19. Chlamydia trachomatis survival in the presence of two fluoroquinolones (lomefloxacin versus levofloxacin) in patients with chronic prostatitis syndrome.
    Smelov V, Perekalina T, Artemenko N, Smelova N, Ukleeva G, Gorelov A.
    Andrologia; 2005 Jun 13; 37(2-3):61-4. PubMed ID: 16026425
    [Abstract] [Full Text] [Related]

  • 20. PSA decrease after levofloxacin therapy in patients with histological prostatitis.
    Guercio S, Terrone C, Tarabuzzi R, Poggio M, Cracco C, Bollito E, Scarpa RM.
    Arch Ital Urol Androl; 2004 Dec 13; 76(4):154-8. PubMed ID: 15693428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.